Synthesis and optimization of novel allylated mono-carbonyl analogs of curcumin (MACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) in rats
Synthesis and optimization of novel allylated mono-carbonyl analogs of curcumin (MACs) act as potent anti-inflammatory agents against LPS-induced acute lung injury (ALI) in rats
复制标题
新型烯丙基化单羰基姜黄素类似物 (MAC) 的合成和优化可作为有效的抗炎剂,对抗 LPS 诱导的大鼠急性肺损伤 (ALI)
DOI:
10.1016/j.ejmech.2016.05.041
复制
发表时间:
2016
影响因子:
6.7
通讯作者:
Liang Guang
中科院分区:
文献类型:
--
作者:
Zhu Heping;Xu Tingting;Qiu Chenyu;Wu Beibei;Zhang Yali;Chen Lingfeng;Xia Qinqin;Li Chenglong;Zhou Bin;Liu Zhiguo;Liang Guang
A series of novel symmetric and asymmetric allylated mono-carbonyl analogs of curcumin (MACs) were synthesized using an appropriate synthetic route and evaluated experimentally thru the LPS-induced expression of TNF-α and IL-6. Most of the obtained compounds exhibited improved water solubility as a hydrochloride salt compared to lead molecule8f. The most active compound7awas effective in reducing the Wet/Dry ratio in the lungs and protein concentration in bronchoalveolar lavage fluid. Meanwhile,7aalso inhibited mRNA expression of several inflammatory cytokines, including TNF-α, IL-6, IL-1β, and VCAM-1, in Beas-2B cells after Lipopolysaccharide (LPS) challenge. These results suggest that7acould be therapeutically beneficial for use as an anti-inflammatory agent in the clinical treatment of acute lung injury (ALI).